Borregaard ASA (BRG.OL)
- Previous Close
185.00 - Open
186.60 - Bid 186.40 x 391200
- Ask 187.20 x 721000
- Day's Range
186.00 - 188.00 - 52 Week Range
151.40 - 209.50 - Volume
22,731 - Avg. Volume
83,499 - Market Cap (intraday)
18.649B - Beta (5Y Monthly) 0.72
- PE Ratio (TTM)
21.32 - EPS (TTM)
8.77 - Earnings Date Jul 16, 2025
- Forward Dividend & Yield 4.25 (2.30%)
- Ex-Dividend Date Apr 11, 2025
- 1y Target Est
229.25
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The company develops, produces, and sells biopolymers and biovanillin for agrochemicals, batteries, industrial binders, and construction, as well as to flavour and fragrance companies, and food and beverage industry. It also develops, produces, and sells speciality cellulose for use as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products; and cellulose fibrils for industrial applications. In addition, the company provides fine chemical intermediates for contrast agents; and advanced bioethanol products. Borregaard ASA was incorporated in 2012 and is headquartered in Sarpsborg, Norway.
www.borregaard.com1,174
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BRG.OL
View MorePerformance Overview: BRG.OL
Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is OBX Total Return Index (OBX.OL) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BRG.OL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BRG.OL
View MoreValuation Measures
Market Cap
18.45B
Enterprise Value
20.58B
Trailing P/E
21.12
Forward P/E
17.99
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.44
Price/Book (mrq)
3.22
Enterprise Value/Revenue
2.72
Enterprise Value/EBITDA
10.84
Financial Highlights
Profitability and Income Statement
Profit Margin
11.38%
Return on Assets (ttm)
8.93%
Return on Equity (ttm)
16.40%
Revenue (ttm)
7.68B
Net Income Avi to Common (ttm)
874M
Diluted EPS (ttm)
8.77
Balance Sheet and Cash Flow
Total Cash (mrq)
191M
Total Debt/Equity (mrq)
40.16%
Levered Free Cash Flow (ttm)
304.75M